Skip to main content
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices

Professional Development

The Leveson Inquiry – one year on and the future for Rupert Murdoch

A magnifying glass rests over blank newspaper pages on a desk in an editorial illustration about press scrutiny.

The Leveson Inquiry – one year on and the future for Rupert Murdoch, with Steve Hewlett, BBC broadcaster, Guardian columnist and media commentator. This Reuters Institute for the Study of Journalism Professional Development event takes place on 11 May 2012 in the Seminar Room, Nuffield College.

Hosted with: Psychedelic Writers Guild